- Report
- August 2023
- 123 Pages
North America
From €1459EUR$1,500USD£1,250GBP
- Report
- August 2023
- 136 Pages
Asia Pacific
From €1459EUR$1,500USD£1,250GBP
- Report
- April 2023
- 150 Pages
Global
From €4719EUR$4,850USD£4,043GBP
- Report
- March 2021
Global
From €3099EUR$3,185USD£2,655GBP
€4427EUR$4,550USD£3,792GBP
- Report
- February 2023
- 30 Pages
Japan
From €2676EUR$2,750USD£2,292GBP
- Report
- March 2022
- 279 Pages
Global
From €3099EUR$3,185USD£2,655GBP
€4427EUR$4,550USD£3,792GBP
- Report
- April 2023
- 115 Pages
Global
From €4622EUR$4,750USD£3,959GBP
- Report
- January 2022
- 115 Pages
Global
From €4622EUR$4,750USD£3,959GBP
- Report
- June 2020
- 110 Pages
Global
From €4622EUR$4,750USD£3,959GBP
- Report
- April 2023
- 180 Pages
Global
From €7297EUR$7,500USD£6,251GBP
- Report
- July 2022
- 196 Pages
Global
From €7297EUR$7,500USD£6,251GBP
- Report
- February 2022
- 269 Pages
Global
From €9243EUR$9,500USD£7,918GBP
- Report
- January 2022
- 200 Pages
Global
From €7297EUR$7,500USD£6,251GBP
- Report
- December 2022
- 120 Pages
Global
From €4378EUR$4,500USD£3,751GBP
- Report
- July 2021
- 158 Pages
Asia Pacific
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- March 2022
- 125 Pages
Global
From €4330EUR$4,450USD£3,709GBP
- Report
- May 2021
- 109 Pages
Global
From €4330EUR$4,450USD£3,709GBP
- Report
- July 2019
- 102 Pages
Global
From €4330EUR$4,450USD£3,709GBP
- Report
- January 2019
- 110 Pages
Global
From €4330EUR$4,450USD£3,709GBP
- Report
- July 2022
- 120 Pages
Global
From €2432EUR$2,500USD£2,084GBP
The Dermatologicals market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin diseases, including acne, psoriasis, eczema, and skin cancer. Dermatologicals are typically administered topically, although some may be taken orally. The market is highly competitive, with a wide range of products available from both generic and branded manufacturers.
The Dermatologicals market is driven by the increasing prevalence of skin diseases, as well as the development of new treatments and technologies. Additionally, the increasing demand for cosmetic treatments has also contributed to the growth of the market.
Some of the major companies in the Dermatologicals market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. Other notable players include Allergan, Galderma, and Sun Pharmaceuticals. Show Less Read more